Kirô Shimamoto
- Molecular Biology
- Cellular and Molecular Neuroscience
- Cardiology and Cardiovascular Medicine
- Physiology
- Pharmacology
- Co-authors
- Noboru TodaMotohatsu FujiwaraShuji TakaoriYumiko ShiboutaYoshiyuki InadaKohei NishikawaShintaro KikuchiZen‐ichi Terashita
- Topics
- Neuroscience and Neuropharmacology Research (6 papers)Pharmacological Receptor Mechanisms and Effects (4 papers)Eicosanoids and Hypertension Pharmacology (4 papers)
- Journals
- JNCI Journal of the National Cancer InstituteJournal of Pharmacology and Experimental TherapeuticsBiochemical Pharmacology
- Partner nations
- Japan
In The Last Decade
Kirô Shimamoto
52 papers receiving 298 citations
Peers
Comparison fields: 5 of 77
- Molecular Biology 98
- Cellular and Molecular Neuroscience 93
- Cardiology and Cardiovascular Medicine 81
- Physiology 76
- Pharmacology 39
Countries citing papers authored by Kirô Shimamoto
This map shows the geographic impact of Kirô Shimamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirô Shimamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirô Shimamoto more than expected).
Fields of papers citing papers by Kirô Shimamoto
This network shows the impact of papers produced by Kirô Shimamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirô Shimamoto. The network helps show where Kirô Shimamoto may publish in the future.
Co-authorship network of co-authors of Kirô Shimamoto
This figure shows the co-authorship network connecting the top 25 collaborators of Kirô Shimamoto. A scholar is included among the top collaborators of Kirô Shimamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kirô Shimamoto. Kirô Shimamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 39 | |
| 3 | 3 | |
| 4 | Therapeutic Mechanisms of Cytidine Diphosphate Choline(CDP-choline) | 2 |
| 5 | Therapeutic Mechanism of Cytidine Diphosphate Choline (CDP-choline) in Parkinsonism | 3 |
| 6 | 7 | |
| 7 | 5 | |
| 8 | 3 | |
| 9 | 56 | |
| 10 | 0 | |
| 11 | 1 | |
| 12 | 15 | |
| 13 | 0 | |
| 14 | 3 | |
| 15 | 1 | |
| 16 | 3 | |
| 17 | 3 | |
| 18 | 2 | |
| 19 | 1 | |
| 20 | 4 |
About Kirô Shimamoto
Kirô Shimamoto is a scholar working on Biochemistry, Cellular and Molecular Neuroscience and Neurology, having authored 55 papers that have together received 345 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (6 papers), Pharmacological Receptor Mechanisms and Effects (4 papers) and Eicosanoids and Hypertension Pharmacology (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (93 citations), Gastroenterology (25 citations) and Biochemistry (32 citations). Kirô Shimamoto has collaborated with scholars based in Japan. Frequent co-authors include Noboru Toda, Motohatsu Fujiwara, Shuji Takaori, Yumiko Shibouta, Yoshiyuki Inada, Kohei Nishikawa, Shintaro Kikuchi, Zen‐ichi Terashita, Masashi Sasa and Yoshio Imai. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.